Exact Mass: 406.05618180000005
Exact Mass Matches: 406.05618180000005
Found 146 metabolites which its exact mass value is equals to given mass value 406.05618180000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lancerin
Lancerin is a C-glycosyl compound that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3, and 7 and a 1,5-anhydro-D-glucitol moiety at position 1. It has a role as a plant metabolite. It is a member of xanthones, a C-glycosyl compound and a polyphenol. Lancerin is a natural product found in Maclura cochinchinensis, Polygala tenuifolia, and other organisms with data available. A C-glycosyl compound that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3, and 7 and a 1,5-anhydro-D-glucitol moiety at position 1. Lancerin, isolated from the root bark of Cudraniu cochinchinensis, possesses anti-lipid peroxidation[1]. Lancerin, isolated from the root bark of Cudraniu cochinchinensis, possesses anti-lipid peroxidation[1].
Rotenonone
7-Chloro-3,4',5,6,8-pentamethoxyflavone
C20H19ClO7 (406.08192540000005)
7-Chloro-3,4,5,6,8-pentamethoxyflavone is found in citrus. 7-Chloro-3,4,5,6,8-pentamethoxyflavone is a constituent of a Citrus sp. (Dancy tangerine). Constituent of a Citrus species (Dancy tangerine). 7-Chloro-3,4,5,6,8-pentamethoxyflavone is found in citrus.
1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate)
1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate) is found in green vegetables. 1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate) is isolated from Pteridium aquilinum (bracken fern).
Carbonyloxycamptothecin
3-Carboxy-11-(2,4-dichlorophenyl)-3,5-dihydroxyundecanoic acid
Glucoiberverin
C11H20NO9S3- (406.03001700000004)
Neolancerin
Neolancerin is a natural product found in Hypericum sampsonii and Gentiana thunbergii with data available. Neolancerin is a natural product with weak cytotoxic activity against HL-60 cells[1].
spongotine A
A member of the class of imidazolines that is 4,5-dihydro-1H-imidazole which is substituted by a 1H-indole-3-carbonyl group at position 2 and a 6-bromo-1H-indol-3-yl group at position 4S. It is a bisindole alkaloid isolated from the marine sponge, Spongosorites sp.
2-(Benzothiazol-2-ylsulfanyl)-1-phenothiazin-10-yl-ethanone
O1-[3-(Trifluoromethyl)benzoyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanehydroximamide
C18H13F3N4O4 (406.08888540000004)
1-[3-(4-Chlorophenylaminocarbonyl)benzyl]-5-(trifluoromethyl)-2-pyridone
Acetyl-2,3,4,6-tetra-O-acetyl-5-thio-d-glucopyranoside
1-chloronephroarctin|4-Chloronephroarctin
C20H19ClO7 (406.08192540000005)
2,9-Dibenzyl-1,8-dioxa-2,9-diaza-dispiro[3.2.3.2]dodeca-5,11-dien-3,10-dithion|2,9-dibenzyl-1,8-dioxa-2,9-diaza-dispiro[3.2.3.2]dodeca-5,11-diene-3,10-dithione
C22H18N2O2S2 (406.08096479999995)
4-chloro-5-O-methyl-3,4-deoxypsorospermin-3,5-diol
C20H19ClO7 (406.08192540000005)
1,5-dihydroxyxanthone-6-O-beta-D-glucoside|1,5-Dihydroxyxanthone-6-O-??-D-glucoside
erigeroflavanone|methyl 2-[rel-(2R,3R)-3,4-dihydro-3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-2-methoxy-4-oxo-2H-chromen-3-yl]acetate|rel-(2R,3R)-3,5,7,3,4-pentahydroxy-2-methoxy-flavanone-3-acetic acid methyl ester
2-(4-Hydroxyphenyl)-5,7-dihydroxy-6-[2-hydroxy-5-(hydroxycarbonyl)phenyl]-4H-1-benzopyran-4-one
3-chloro-3,5,7,8,2-pentamethoxyflavone
C20H19ClO7 (406.08192540000005)
6-oxo-6a,12a-dehydrodeguelin|9,10-dimethoxy-3,3-dimethyl-3H-pyrano[2,3-c;6,5-f] dichromium ene-7,13-dione|9,10-Dimethoxy-3,3-dimethyl-3H-pyrano[2,3-c;6,5-f]dichromen-7,13-dion|villosinol
3,4-dihydro-7-hydroxy-4-(3,4-dihydroxyphenyl)-5-[(1E)-2-(3,4-dihydroxyphenyl)ethenyl]-2H-1-benzopyran-2-one|gnetumontanin F
16,16-dibromohexadec-15-en-5-ynoic acid
C16H24Br2O2 (406.01429239999993)
4-O-beta-D-glucopyranosyl-1,7-dihydroxyxanthone|tenuiside A
3-(1H-Indole-3-yl)-6-(6-bromo-1H-indole-3-yl)-1,2,5,6-tetrahydropyrazine-2-one
3-(6-Bromo-1H-indole-3-yl)-6-(1H-indole-3-yl)-1,2,5,6-tetrahydropyrazine-2-one
1,7-dihydroxyxanthone-3-O-beta-D-glucopyranoside|xanthohypericoside
7-Chloro-3,4',5,6,8-pentamethoxyflavone
C20H19ClO7 (406.08192540000005)
1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate)
N-(5-Chloro-2-pyridinyl)-2-[(4-cyanobenzoyl)amino]-5-methoxybenzamide
2-(4-(8-BROMO-2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL)PHENYL)-2-METHYLPROPANENITRILE
[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-acetylsulfanyloxan-2-yl]methyl acetate
(R)-4-(2-(IODOMETHYL)-3-METHYLBUTYL)-1-METHOXY-2-(3-METHOXYPROPOXY)BENZENE
(4-Fluorobenzyl)(triphenyl)phosphonium chloride
C25H21ClFP (406.10533580000003)
Bis(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate
3,4-Bis(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)benzamide
C20H20Cl2N2O3 (406.08509100000003)
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
C16H12F6N4O2 (406.08644039999996)
Piperazine-N,N-bis(2-hydroxypropanesulphonic acid) disodium salt
((3,5-DICHLORO-4-(3-ISOPROPYL-4-METHOXYPHENOXY)PHENYL)ETHYNYL)TRIMETHYLSILANE
C21H24Cl2O2Si (406.09225439999994)
1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluoro-8-(propoxy)octane
Remoxipride hydrochloride
(S)-Remoxipride ((-)-Remoxipride) hydrochloride is a selective dopamine D2-receptor antagonist with an IC50 value of 1.57 μM. (S)-Remoxipride hydrochloride can be used for the research of psychotic disorder[1].
Fosphenytoin sodium
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators
N-[5-(diethylamino)-2-[(3,5-dinitro-2-thienyl)azo]phenyl]acetamide
C16H18N6O5S (406.10593380000006)
2,6-Diazaspiro[3.3]heptane, 2,6-bis[(4-Methylphenyl)sulfonyl]-
9,10-Anthracenedione,1-amino-2-bromo-4-[(4-methylphenyl)amino]-
D-Xylonic Acid Calcium Salt Hydrate
C10H22CaO14 (406.06354220000003)
CPPHA
C22H15ClN2O4 (406.07203000000004)
CPPHA is potent and selective positive allosteric modulator (PAM) of the mGluR5 and mGluR1 (metabotropic glutamate receptor). CPPHA can potentiate responses of mGluR5 and mGluR1 to activation of these receptors. CPPHA is developed for the research of central nervous system disorders[1][2].
cis-2-(2,4-dichlorophenyl)-2-(1h-imidazole-1-yl)methyl-4-(methane sulfonyloxy)methyl-1,3-dioxalane
2-(4-((2-(3-Chlorophenyl)-6-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acetamide
Peficitinib hydrobromide
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
2,3-Dicarboxy-4-(2-chloro-phenyl)-1-ethyl-5-isopropoxycarbonyl-6-methyl-pyridinium
C20H21ClNO6+ (406.10573360000006)
(2E)-3-{3-[(5-Ethyl-3-iodo-6-methyl-2-oxo-1,2-dihydropyridin-4-YL)oxy]phenyl}acrylonitrile
C17H15IN2O2 (406.01782399999996)
(2r)-2-[(1r)-1-{[(2s)-2-Carboxy-2-(4-Hydroxyphenyl)acetyl]amino}-1-Methoxy-2-Oxoethyl]-5-Methylidene-5,6-Dihydro-2h-1,3-Oxazine-4-Carboxylic Acid
C18H18N2O9 (406.10122580000007)
Zimeldine hydrochloride
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators
3-Ethyl-3,6,6-trihydroxy-5-oxa-9,19-diazahexacyclo[15.4.1.02,7.09,21.011,20.013,18]docosa-1(21),2(7),11(20),12,14,16,18-heptaene-4,8,22-trione
3-Thiophenecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
2-[(3-Cyano-4-thiophen-2-yl-5,6,7,8-tetrahydroquinolin-2-yl)thio]-2-phenylacetic acid
C22H18N2O2S2 (406.08096479999995)
2-[(5Z)-5-(1-methyl-2-oxoindol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]pentanedioic acid
N-[2-methoxy-5-(2-oxo-1-benzopyran-3-yl)phenyl]-5-nitro-2-furancarboxamide
N-[(5-bromo-2-methoxyphenyl)methyl]-4-methyl-2,3-dihydro-1,4-benzothiazine-6-carboxamide
2-[(E)-{2-[(3-fluorophenyl)carbonyl]hydrazinylidene}methyl]phenyl 1,3-benzodioxole-5-carboxylate
4-Nitrobenzoic acid [3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]methyl ester
N-[(E)-[5-(3-chloro-4-methylphenyl)furan-2-yl]methylideneamino]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide
(2S)-2-[(4S,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C15H23BrN2O4S (406.05618180000005)
(2R)-2-[(4R,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C15H23BrN2O4S (406.05618180000005)
(2S)-2-[(4R,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C15H23BrN2O4S (406.05618180000005)
(2S)-2-[(4S,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C15H23BrN2O4S (406.05618180000005)
(2R)-2-[(4R,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C15H23BrN2O4S (406.05618180000005)
(2R)-2-[(4S,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C15H23BrN2O4S (406.05618180000005)
(2S)-2-[(4R,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C15H23BrN2O4S (406.05618180000005)
1-(4-Chlorophenyl)-3-[3-(3-chlorophenyl)-1,5,5-trimethyl-2-oxoimidazolidin-4-yl]urea
2-Thiophenecarboxylic acid 4-[[5-(2-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
(2R)-2-[(4S,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C15H23BrN2O4S (406.05618180000005)
2-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy-3-sulooxybutanedioic acid
C14H14O12S (406.02059640000004)
[2-Hydroxy-5-[3-(4-methoxy-1-benzouran-5-yl)-3-oxopropanoyl]phenyl] hydrogen sulate
C18H14O9S (406.03585140000007)
2-[3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonooxybutanoyl]amino]propanoylamino]ethanesulfonic acid
glucoiberverin(1-)
C11H20NO9S3 (406.03001700000004)
A thia-alkylglucosinolate resulting from the removal of the proton of the hydrogen sulfate group of glucoiberverin.
5,5',6,6',7,7'-hexahydroxy-3-methoxy-4,8'-dimethyl-1'h,3h-spiro[2-benzofuran-1,3'-[2]benzopyran]-4'-one
methyl 5-hydroxy-3-methoxy-4-methyl-7-{2-[2-(prop-1-en-2-yl)-1,3-thiazol-4-yl]-1,3-thiazol-4-yl}hepta-2,6-dienoate
(5r)-3-(6-bromo-1h-indol-3-yl)-5-(1h-indol-3-yl)-5,6-dihydro-1h-pyrazin-2-one
methyl 13-chloro-15-formyl-6,14-dihydroxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylate
2-chloro-1,3,6,8-tetrahydroxy-7-[(1s)-1-hydroxyhexyl]anthracene-9,10-dione
C20H19ClO7 (406.08192540000005)
2-chloro-1,3,6,8-tetrahydroxy-7-(1-hydroxyhexyl)anthracene-9,10-dione
C20H19ClO7 (406.08192540000005)